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Abstract 
Objective: To identify clinical, laboratorial and radiographic predictors for Bordetella 
pertussis infection. 
Methods: This was a retrospective study, which analyzed medical records of all patients 
submitted to a molecular dignosis (qPcR) for B. pertussis from September 2011 to 
January 2013. clinical and laboratorial data were reviewed, including information about 
age, sex, signs/symptoms, length of hospitalization, blood cell counts, imaging findings, 
coinfection with other respiratory pathogens and clinical outcome. 
Results: 222 cases were revised. of these, 72.5% had proven pertussis, and 60.9% were 
under 1 year old. In patients aging up to six months, independent predictors for B. 
pertussis infection were (oR 8.0, cI 95% 1.8-36.3; p=0.007) and lymphocyte count 
>104/µL (oR 10.0, cI 95% 1.8-54.5; p=0.008). no independent predictors of B. pertussis 
infection could be determined for patients older than six months. co-infection was 
found in 21.4% of patients, of which 72.7% were up to six months of age. Adenovirus 
was the most common agent (40.9%). In these patients, we were not able to identify 
any clinical features to detect patients presenting with a respiratory co-infection, even 
though longer hospital stay was observed in patients with co-infections (12 vs. 6 days; 
p=0.009). 
☆Study conducted at Irmandade Santa casa de Misericórdia de Porto Alegre, Porto Alegre, RS, Brazil.
*corresponding author. 
    E-mail: acpasqualotto@hotmail.com (A.c. Pasqualotto).
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Introduction
Pertussis or whooping cough is an acute respiratory tract 
infection caused by Bordettella pertussis and ranked 
among the 10 leading causes of childhood mortality.1 
An increasing number of pertussis outbreaks have been 
reported in the last years despite vaccination coverage. 
Indeed, in the last decades, the age range of affected 
individuals appears to have widened and the incidence 
of pertussis in adolescents and adults has raised.2-5 It is 
essential the prompt recognition of patients with this 
condition, because a delay in diagnosis could result in late 
onset of antibiotic treatment subsequently increasing the 
potential for secondary transmission.6 However, clinical 
diagnosis of whooping cough is difficult to perform, once 
clinical manifestations can vary according to immunization 
status, patient’s age and the disease stages.3,5,7-8
Previous studies have evaluated the impact of concomitant 
detection of B. pertussis with other respiratory agents9-10, 
suggesting that B. pertussis infection could be more severe 
in this context.11-13 Mixed respiratory infections have been 
reported in children in several countries,14 but its actual 
incidence is believed to be even higher.12-13
The purpose of this study was to describe the clinical 
profile of patients with suspected B. pertussis infection, 
and to identify the clinical, laboratorial and radiographic 
predictors for B. pertussis infection. We also aimed to 
determine the frequency of concomitant respiratory tract 
infections in this population, as well as to determine if 
co-infections were associated with greater morbidity and/
or mortality in patients with B. pertussis infection. 
Methods
This was a retrospective case series study performed at 
Santa casa de Misericórdia de Porto Alegre, Brazil, from 
September 2011 to January 2013. We studied patients with 
suspected B. pertussis infection for whom a molecular 
diagnosis was performed at Molecular Biology Laboratory at 
Santa casa. We included hospitalized patients, and patients 
with suspected infection that attended the emergency 
Conclusions: cyanosis and lymphocytosis are independent predictors for pertussis in 
children up to 6 months old.
© 2014 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. All rights 
reserved.
Preditores clínicos, laboratoriais e radiográficos para infecção por Bordetella 
pertussis  
resumo 
Objetivo: Identificar preditores clínicos, laboratoriais e radiológicos da infecção por 
Bordetella pertussis.
Métodos: Trabalho retrospectivo, com análise de prontuários clínicos de todos os indi-
víduos submetidos ao diagnóstico molecular (qPcR) para Bordetella pertussis de setem-
bro de 2011 à janeiro de 2013. Foram revistos dados clínicos e laboratoriais, incluindo 
informações sobre idade, sexo, sinais/sintomas, tempo de hospitalização, contagens de 
células sanguíneas, exames de imagem, co-infecção com outros patógenos respiratórios, 
e evolução clínica. 
Resultados: 222 casos foram revistos, do quais 72,5% tinham coqueluche confirmada, 
sendo 60,9% menores de um ano de idade. Foram observados preditores independentes 
para Bordetella pertussis em pacientes com menos de seis meses de idade. nesses casos, 
os preditores identificados foram cianose (oR 8,0; cI 95% 1,8-36,3; p=0,007) e contagem 
de linfócitos >104/µL (oR 10,0; cI 95% 1,8-54,5; p=0,008). Preditores de coqueluche não 
puderam ser determinados para crianças maiores de 6 meses de idade. co-infecção foi 
encontrada em 21,4% dos pacientes, dos quais 72,7% tinham até seis meses de idade, 
sendo que o adenovírus foi o agente mais comum (40,9%). nesses indivíduos, não foram 
observadas características clíncias capazes de distinguir pacientes com co-infecção, 
porém foi verificado um maior tempo de internação hospitalar nos pacientes com mais 
de um agente infeccioso detectado (12 vs. 6 dias; p=0,009).
Conclusões: cianose e linfocitose são preditores independentes para coqueluche em 
crianças com até seis meses de idade. 
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. Todos os 
direitos reservados.
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room or physician’s office in the hospital. All patients who 
were tested for pertussis by real time polymerase chain 
reaction (qPcR) in the study period, regardless of age, 
were studied. clinical samples consisted of nasopharyngeal 
aspirates collected by hospital’s nursing team. clinical 
and laboratorial data were extracted by a standardized 
clinical form, including information about age, sex, signs/
symptoms, length of hospitalization, blood cells count, 
chest imaging findings, concomitant detection of other 
respiratory pathogens and clinical outcome. This study was 
approved by the local Ethic committee (n. 115333), and all 
researchers signed a commitment statement to use patient’s 
records, ensuring the confidentiality of this work.
The in house qPcR test used in this study has been available 
in the institution since 2011. In summary, DnA was extracted 
with QIAamp DnA Mini Kit (Qiagen) and stored at -80ºc. 
qPcR was performed using Platinum® SYBR® green qPcR 
SuperMix-UDg (Invitrogen™). Primers (0.2uM each) were 
AcgcAgTggccTAcTAccAg and gcggTAAggTcgggTAAAg. 
All reactions included a positive control (DnA extracted 
from Fiocruz ATcc strain), a negative control and an internal 
control (HuPo), in 25ul reactions. The qPcR conditions were 
2 min at 50ºc, 5 min at 95ºc, 45 cycles of 15 sec at 95ºc and 
30 sec at 60ºc, followed by 15 sec at 95ºc, 1 min at 60ºc, 
30 sec at 95ºc, and 15 sec at 60ºc. A positive qPcR test 
was assumed as a confirmatory test for pertussis, while a 
negative qPcR was considered as absence of the disease. 
Statistical analyzes were performed by SPSS software 
(version 17.0). Patients with positive and negative qPcR 
results for B. pertussis were compared. chi-squared test was 
used for categorical variables and the Mann-Whitney test was 
applied for continuous data. Significance was determined 
at α<0.05. Multivariate analysis was performed in order to 
identify independent predictors for B. pertussis infection. 
results
Medical records of 222 patients with suspected B. pertussis 
infection were reviewed. Among these, qPcR confirmed 
B. pertussis infection in 161 (72.5%) patients. The great 
majority was tested by qPcR only. Four patients were also 
submitted (and tested negative) to additional diagnostic 
test, including serology and culture. Among positive qPcR 
cases, 60.9% were younger than 1 year, and 52.8% were 
boys. Table 1 shows the age distribution according to 
qPcR results. The most common clinical manifestations 
were cough (100%), cyanosis (59.6%), plethora (49.7%), 
posttussive vomiting (37.9%), fever (34.2%), respiratory 
effort (36%) and whoop (15.5%). Most of patients with 
cyanosis were up to one year (81.3%), but this sign was also 
observed in older children and adolescents up to 13 years 
old. The median time interval between the beginning of 
symptoms and the sample submission for qPcR testing 
was 15 days (range, 1-60 days), versus 19 days in qPcR 
negative group (p=0.49). In the positive qPcR patients, 
the main alteration on chest X-ray was diffuse infiltrate 
(58.3%), followed by hyperinflated lungs (22.8%) and 
atelectasis (16.5%). Mean [range] blood cells (% where 
indicated) for patients with B. pertussis infection were 
as follows: 21,607 [6,470-99,700] (white blood cells); 
 qPcR (n)  
Age negative Positive Total
0-1 month 4 23 27
2-6 months 15 60 75
7-12 months 13 15 28
1-4 years 12 31 43
5-9 years 11 17 28
10-19 years 5 13 18
40-59 years 1 2 3
Total 61 161 222
qPcR, real time polymerase chain reaction test
Table 1 Age distribution and qPcR results in patients with 
suspected pertussis infection.
Table 2 clinical and laboratorial data of patients with positive and negative pertussis qPcR.
 n qPcR positive qPcR negative p-value odds Ratio (95% cI)
clinical findings
 Age months (median) 222 6.0 12.0 0.027 
 Cyanosis 222 96 (59.6%) 20 (32.8%) <0.0001 3.03 [1.62 – 5.63]
 Plethora 222 80 (49.7%) 14 (23.0%) <0.0001 3.31 [1.69 – 6.49]
 Whoop 222 25 (15.5%) 01 (1.60%) 0.004 11.02 [1.46 – 83.28]
 Post tussive vomiting 222 61 (37.9%) 19 (31.1%) 0.3 1.34 [0.71 – 2.52]
chest X-ray alterations 
 Diffuse infiltrate 179 74 (58.3%) 26 (50.0%) 0.3 1.39 [0.73 – 2.66]
 Hyperinflated 179 29 (22.8%) 07 (13.5%) 0.1 1.9 [0.77 – 4.66]
 Atelectasis 179 21 (16.5%) 15 (28.8%) 0.6 0.48 [0.22 – 1.04]
Laboratorial (mean) 
 Leukocyte count /µL  137 21.607 13.011 <0.0001 
 Lymphocyte count /µL  137 11.515 4.989 <0.0001 
 Percentage of lymphocytes 137 53.6 36.4 <0.0001 
 Platelet count /µL  137 503.205 422.971 0.019
CI, confidence interval; qPCR, real time polymerase chain reaction test
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11,515 [367-43,908] (lymphocytes); 53.6% [5.5-78.0%] 
(percentage of lymphocytes); and 503,205 [150,000-
946,000] (platelets). overall mortality in patients with B. 
pertussis infection was 2.5%; all occurring in patients 3 
months of age or younger. comparisons of the clinical and 
laboratorial data of patients with positive and negative 
qPcR results for pertussis are presented in Table 2. 
From all of our patients, 164 were hospitalized (73.8%). 
Hospitalization rate in age up to 6 months was 94% 
(versus 56.6% of patients older than 6 months; p<0.001). 
Besides age, laboratorial features were also predictors 
of hospitalization in pertussis: lymphocytosis (p=0.001), 
leukocytosis (p=0.001) and thrombocytosis (p<0.001). 
There was no statistic significant difference between these 
groups (hospitalized vs. outpatient) in relation to qPcR 
result (75.1% in qPcR+ vs. 70.4% in qPcR-; p=0.4) and 
presence of co-infections (95% in coinfected vs. 91.3% in 
no coinfected p=0.5).
Immunization data was reported only in 54.5% of cases. 
Data available showed that 62% of positive and 31% of 
negative cases had received any or only one dose of the 
vaccine against B. pertussis, while only 6.5% of positive 
cases (versus 20.7% of negative cases) had complete 
immunization [in Brazil, this consists in 3 doses and 2 
boosters of the vaccine]. Despite this percentage contrast, 
there was no statistic significant difference between the 
groups (p=0.068). Immunization received according to age 
group is demonstrated in Table 3.
We divided patients in two different groups: children 
aged 6 months or younger and patients older than 6 months. 
Predictors of B. pertussis infection at univariate analysis for 
patients aged 6 months or younger were cyanosis (oR 5.32, 
cI 95% 1.79-15.8; p=0.001), plethora (oR 4.49, cI 95% 1.54-
13.1; p=0.004), leukocyte count (p=0.031), lymphocyte 
count (p<0.0001), and percentage of lymphocytes 
(p=0.002). At multivariate analysis, cyanosis (oR 8.0, cI 
95% 1.8-36.3; p=0.007) and lymphocyte count >104 /µL 
(oR 10.0, cI 95% 1.8-54.5; p=0.008) were independent 
predictors for pertussis in children younger than 6 months 
of age. The only variables associated with pertussis for 
patients aged more than 6 months at univariate analysis 
were leukocyte count (p=0.019) and lymphocyte count 
(p=0.018). Atelectasis was associated with the presence of 
diagnoses other than pertussis (oR 0.2, cI 95% 0.07-0.88; 
p=0.024), in this group of patients. At multivariate analysis, 
no variable was associated with pertussis in patients older 
than 6 months of age.
A total of 103 patients with confirmed B. pertussis 
infection were also tested for other respiratory pathogens 
[also detected by in house qPcR or bacterial culture]. 
co-detection was found in 21.4% of these patients, 72.7% of 
whom were 6 months of age or younger, 13.6% were older 
than 6 months but younger than 1 year, and 13.6% were 
between 1 and 4 years old. Fig. 1 displays the frequency of 
co-detection of other respiratory pathogens in patients with 
pertussis. There was no statistically significant difference 
between age and pathogens distribution (p=0.71). Patients 
with co-detection of pertussis and other respiratory 
pathogens had prolonged stay in the hospital (12 vs. 6 days; 
p=0.009) and more atelectasis on chest X-ray (38.1% vs. 
16.7%; oR 3.3, cI 95% 1.1-9.5; p=0.023). 
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discussion
In this work, we reviewed the clinical charts of 222 
patients suspected of B. pertussis infection. of these, 
the diagnosis of pertussis was confirmed in 72.5% by the 
means of qPcR. considering that only four patients were 
also submitted to another diagnostic test for comparison 
(serology or culture), we assumed that negative qPcR 
indicated absence of the disease. Even though, all 
patients were in a similar moment of disease by the time 
of molecular diagnosis. 
As expected, most of these children were aged 1 year of 
age or less (60.9%), which is in accordance with previous 
data that reported rates between 50% and 64.6% in this 
age group.15-16 Recently, it was reported a significant 
increase in the incidence of pertussis in adolescents and 
adults.2-3 However, in this study, few individuals with 
positive qPcR were older than 15 years (1.8%). This fact 
could be justified by the heterogeneity in the clinical 
manifestations of pertussis, in association with a low 
index of suspicion among clinicians for such condition in 
adults.3,17-20
It is well known that pertussis may present different 
manifestations according to patients’ age, among 
children.3,5,8,21-22 In this work, we stratified patients in two 
separated groups: children aged 6 months or less and patients 
older than 6 months. our results suggest that classical 
manifestations of pertussis vary according to patients’ age 
and presumably to the number of vaccine doses against B. 
pertussis they receive. For instance, in younger children 
(i.e., <6 months of age), pertussis was associated with the 
presence of cyanosis, plethora, leukocyte count, lymphocyte 
count and lymphocytes percentage. Multivariate analysis 
showed that cyanosis and lymphocyte count were able to 
predict pertussis in this patient group. on the other hand, 
older patients (i.e., >6 months of age) presented with less 
classical symptoms of pertussis, and no variable could be 
independently associated with pertussis. This is similar to 
previously reported data, showing that patients who were 
immunized against pertussis may develop the disease with 
atypical presentations.5,6,18-20 The most common typical 
finding, which appears to be present in all age groups, is 
prolonged cough.7,18-19
cyanosis is already known as a pertussis classic 
symptom,2,8 and leukocytosis attributable to lymphocytosis 
is also recognized as a hallmark of pertussis.7,23-25 In this 
study, lymphocytosis was not only a hallmark, but also was 
an independent predictor for B. pertussis infection in young 
infants. The cutoff point (104/µL) was similar with those 
found in previous studies.24,25 These data suggest that the 
occurrence of cyanosis should increase the pediatrician´s 
suspicion of B. pertussis infection, particularly in the 
presence of lymphocytosis in a young child.
co-detection of B. pertussis with other respiratory 
agents has already been reported,12,22,26-29 and it may be 
actually underestimated.12-13 It was reported that pertussis 
toxin may suppress innate immune response and sensitize 
the host to a secondary respiratory pathogen.13 In our 
study, we found an incidence of 21.4% of mixed infections; 
the most frequent pathogens associated with B. pertussis 
were adenovirus, RSV and parainfluenza type 3 virus. 
These viruses (especially RSV) were also prevalent in some 
previous reports.22,26-29 The evaluation of laboratorial data of 
infants up to 6 months showed that lymphocyte percentage 
Respiratory pathogens
0% 20% 40% 60% 80% 100%
40.9%
22.7%
22.7%
9.0%
9.0%
4.5%
4.5%
4.5%
Adenovirus
Human respiratory syncytial virus (RSV)
Human parainfluenza virus 3
Influenza B virus
Human metapneumovírus
Human parainfluenza virus 1
Human bocavirus
Pseudomonas aeruginosa
Figure 1 Frequency of codetection of other respiratory pathogens in patients with Bordetella pertussis infection
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is significant different (and higher) among patients with 
respiratory pathogens co-detection and patients with only 
pertussis identification. Previous studies related mixed 
infection with higher severity of the disease.11-13 In this 
work, patients with co-detection pathogens had a longer 
period of hospitalization, reinforcing the relationship 
between mixed infection and a more severe disease. on 
the other hand, as reported in other works, we did not 
reliably distinguish clinical features of infants with mixed 
infection from those with only pertussis detection.11-12,22,26-27 
Furthermore, it is important to note that less than 50% 
of our patients were tested to other patogens, and these 
results must be seen with caution.
This study has some limitations that should be mentioned. 
In view of its retrospective design and the samples were 
obtained by convenience, some data were missing at 
analysis, particularly those related to immunization history, 
clinical and laboratorial exams, and co-infection tests. 
Despite that were to study a large number of patients, and 
for most of the other variables data missing was minimal. 
Another limitation is related to the limited number of adult 
patients included in the study – therefore, our conclusion 
cannot be extrapolated to this patient group. 
An increasing number of pertussis outbreaks have been 
reported despite vaccination coverage.2-5 It is unclear the 
factor that contribute to pertussis resurgence, but waning 
immunity, improved surveillence and diagnosis, as well as 
adaptation of circulating Bordetella pertussis strains could 
be involved.5 Even though, the most important and effective 
way to control pertussis remains vaccination.5 Ensuring 
wider immunization coverage, as well as developing 
newer strategies to avoid waning immunity after pertussis 
vaccination and disease – as booster vaccines in adolescents 
and adults – is something highly desirable.2,4,5
B. pertussis infection is a common disease affecting 
all ages. clinicians should be aware of this condition 
and perform a prompt diagnosis and initiate an early 
treatment, avoiding secondary transmission of the disease. 
This work showed that young children may manifest clinical 
and laboratorial features that may help the clinician to 
suspect the presence of pertussis. Although children with 
6 months or more and adults may present with atypical 
manifestations of pertussis, the diagnosis must be always 
considered in these patients, in the presence of prolonged 
cough.
Conflicts of interest
The authors declare no conflitcts of interest.
references
1.  World Health organization [homepage on the Internet]. 
Immunization surveillance, assessment and monitoring [cited 
2013 Jun 01]. Available from: http://www.who.int/
immunization_monitoring/diseases/pertussis/en/index.html
2. Mattoo S, cherry JD. Molecular pathogenesis, epidemiology, 
and clinical manifestations of respiratory infections due to 
Bordetella pertussis and other Bordetella subspecies. clin 
Microbiol Rev 2005;18:326-82.
3.  cherry JD, grimprel E, guiso n, Heininger U, Mertsola J. 
Defining pertussis epidemiology: clinical, microbiologic and 
serologic perspectives. Pediatr Infect Dis J 2005;24 (Suppl 
5):S25-34.
4. gregory DS. Pertussis: a disease affecting all ages. Am Fam 
Physician 2006;74:420-6. 
5. Hong JY. Update on pertussis and pertussis immunization. 
Korean J Pediatr 2010;53:629-33.
6. Tozzi AE, Ravà L, Ciofi degli Atti ML, Salmaso S; The Progetto 
Pertosse Working group. clinical presentation of pertussis in 
unvaccinated and vaccinated children in the first six years of 
life. Pediatrics 2003;112:1069-75.
7. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis 
and management of pertussis. cMAJ 2005;172:509-15.
8.  Mackey JE, Wojcik S, Long R, callahan JM, grant WD. Predicting 
pertussis in a pediatric emergency department population. 
clin Pediatr (Phila) 2007;46:437-40.
9. Van Kruijssen AM, Templeton KE, van der Plas Rn, van Doorn 
HR, claas Ec, Sukhai Rn et al. Detection of respiratory 
pathogens by real-time PcR in children with clinical suspicion 
of pertussis. Eur J Pediatr 2007;166:1189-91.
10. Legru E, Lubrano M, Lemée L, Marquet c. Acute RSV bronchio-
litis: should we be looking for pertussis? Arch Pediatr 
2009;16:283-4.
11.  Moshal KL, Hodinka RL, Mcgowan KL. concomitant viral and 
Bordetella pertussis infections in infants. Pediatr Infect Dis J 
1998;17:353-4.
12.  Zouari A, Touati A, Smaoui H, Brun D, Kasdaghli K, Menif K et 
al. Dual infection with Bordetella pertussis and Mycoplasma 
pneumonia in three infants: case reports. Infection 2012;40: 
213-7.
13.  Ayala VI, Teijaro JR, Farber DL, Dorsey Sg, carbonetti nH. 
Bordetella pertussis infection exacerbates influenza virus 
infection through pertussis toxin-mediated suppression of 
innate immunity. PLoS one 2011;6:e19016
14.  Heininger U, Burckhardt MA. Bordetella pertussis and 
concomitant viral respiratory tract infections are rare in children 
with cough illness. Pediatr Infect Dis J 2011;30:640-4.
15.  Donoso A, ArrIagada D, cruces P, Díaz Pc. Severe pertussis: 
state of the art. Rev chilena Infectol 2012;29:290-306.
16. Brasil – Ministério da Saúde. - SInAn [homepage on the 
Internet]. Brasília – Acesso ao sistema [cited 2013 May 1]. 
Available from: http://aplicacao.saude.gov.br/sinan 
17.  centers for Disease control and Prevention [homepage on the 
Internet]. guidelines for the control of pertussis outbreaks 
[cited 2013 May 1] Available from: http://www.cdc.gov/
pertussis/outbreaks/index.html
18.  Yaari E, Yafe-Zimerman Y, Schwartz SB, Slater PE, Shvartzman 
P, Andoren n et al. clinical manifestations of Bordetella 
pertussis infection in immunized children and young adults. 
chest 1999;115:1254-8.
19.  Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith 
B et al. Pertussis is a frequent cause of prolonged cough illness in 
adults and adolescents. clin Infect Dis 2001;32:1691-7.
20.  Srugo I, Benilevi D, Madeb R, Shapiro S, Shohat T, Somekh E et 
al. Pertussis infection in fully vaccinated children in day-care 
centers, Israel. Emerg Infect Dis 2000;6:526-9.
21.  cherry JD, Tan T, Wirsing von König cH, Forsyth KD, Thisyakorn 
U, greenberg D et al. Clinical definitions of pertussis: Summary 
of a global Pertussis Initiative roundtable meeting, 2011. clin 
Infect Dis 2012;54:1756-64.
22.  cosnes-Lambe c, Raymond J, chalumeau M, Pons-catalano c, 
Moulin F, de Suremain n et al. Pertussis and respiratory syncytial 
virus infections. Eur J Pediatr 2008;167:1017-9.
23.  Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in 
Bordetella pertussis infections: results of a prospective 
multicenter surveillance study. Pediatrics 1997;100:E10.
298 Belletini cV et al
24. gordon M, Davies HD, gold R. clinical and microbiologic 
features of children presenting with pertussis to a canadian 
pediatric hospital during an eleven-year period. Pediatr Infect 
Dis J 1994;13:617-22.
25. guinto-ocampo H, Bennett JE, Attia MW. Predicting pertussis in 
infants. Pediatr Emerg care 2008;24:16-20
26. nuolivirta K, Koponen P, He Q, Halkosalo A, Korppi M, Vesikari 
T, Helminen M. Bordetella pertussis infection is common in 
nonvaccinated infants admitted for bronchiolitis. Pediatr Infect 
Dis J 2010;29:1013-5.
27. Versteegh Fg, Weverling gJ, Peeters MF, Wilbrink B, Veenstra-
van Schie MT, van Leeuwen-gerritsen JM et al. community-
acquired pathogens associated with prolonged coughing in 
children: a prospective cohort study. clin Microbiol Infect 
2005;11:801-7.
28. Jackson LA, cherry JD, Wang SP, grayston JT. Frequency 
of serological evidence of Bordetella infections and mixed 
infections with other respiratory pathogens in university 
students with cough illnesses. clin Infect Dis 2000;31: 
3-6.
29. Van Kruijssen AM, Templeton KE, van der Plas Rn, van Doorn 
HR, claas Ec, Sukhai Rn et al. Detection of respiratory 
pathogens by real-time PcR in children with clinical suspicion 
of pertussis. Eur J Pediatr 2007;166:1189-91.
